Peloton Therapeutics Lands $18,000,000 Series A Financing Round

  • Feed Type
  • Date
    7/27/2011
  • Company Name
    Peloton Therapeutics
  • Mailing Address
    1700 Owens Street San Francisco, CA 94158
  • Company Description
    Working in close collaboration with scientists at UT Southwestern, Peloton is advancing a promising discovery and development pipeline, comprised of several small molecule-based programs, each with a distinct target and mechanism of action. Peloton’s vision is to become a major biotech company in Dallas with a passion for discovering and developing novel cancer drugs.
  • Website
    http://www.pelotontherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Peloton officials said the company will focus initially on advancing several well differentiated oncology programs, each of which has already yielded promising lead compounds with novel mechanisms of action.
  • M&A Terms
  • Venture Investor
    The Column Group
  • Venture Investor
    Undisclosed

Trending on Xconomy